Experience with mebendazole in the treatment of inoperable hydatid disease in England
- 31 December 1982
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 76 (4), 510-518
- https://doi.org/10.1016/0035-9203(82)90151-1
Abstract
Eleven heterogeneous patients with inoperable hydatid disease were treated with high doses of oral mebendazole, up to 200 mg/kg/day for 16 to 48 weeks. Toxicity was not encountered. Despite careful assessment it proved difficult critically to evaluate the efficacy of mebendazole. In four patients chemotherapy appeared to have been at least partially successful and success seems to have correlated with serum levels in excess of 100 ng/ml one to three hours after dosage. The problems of assessment are discussed and the need for controlled trials of mebendazole in hydatid disease are stressed.Keywords
This publication has 6 references indexed in Scilit:
- Bioavailability and tolerability of mebendazole in patients with inoperable hydatid diseaseTransactions of the Royal Society of Tropical Medicine and Hygiene, 1982
- Clinical pharmacokinetics of high dose mebendazole in patients treated for cystic hydatid diseaseEuropean Journal of Clinical Pharmacology, 1982
- Alveolar Hydatid DiseaseThe American Journal of Tropical Medicine and Hygiene, 1980
- Procedures for testing the viability of human hydatid cysts following surgical removal, especially after chemotherapyTransactions of the Royal Society of Tropical Medicine and Hygiene, 1980
- Complication of mebendazole treatment for hydatid disease.BMJ, 1979
- MEDICAL TREATMENT FOR HYDATIDSThe Medical Journal of Australia, 1978